The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...
Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people. New automated insulin delivery pumps have significantly improved diabetes care, ...
InvestorsHub on MSN
MannKind shares climb after FDA clears revised Afrezza prescribing label
MannKind Corporation (NASDAQ:MNKD) shares gained 3.5% on Monday after the company said the U.S. Food and Drug Administration ...
Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...
The FDA has cleared NovoLog (insulin aspart [rDNA origin] injection) from Novo Nordisk for continuous subcutaneous insulin infusion (CSII) by external insulin pump in pediatric patients aged 4-18 ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully ...
Tandem Diabetes Care (TNDM) begins global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus CGM sensor, expanding choice and personalization for people living with ...
Automated insulin delivery pump proved cost-effective in the treatment of type 1 diabetes in Finland
Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people. New automated insulin delivery pumps have significantly improved diabetes care, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results